NO951629L - Konjugat vaksine mot gruppe B streptococcus - Google Patents
Konjugat vaksine mot gruppe B streptococcusInfo
- Publication number
- NO951629L NO951629L NO951629A NO951629A NO951629L NO 951629 L NO951629 L NO 951629L NO 951629 A NO951629 A NO 951629A NO 951629 A NO951629 A NO 951629A NO 951629 L NO951629 L NO 951629L
- Authority
- NO
- Norway
- Prior art keywords
- streptococcus
- vaccine against
- conjugate vaccine
- against group
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96886692A | 1992-11-02 | 1992-11-02 | |
| PCT/US1993/010506 WO1994010317A2 (en) | 1992-11-02 | 1993-11-02 | Conjugate vaccine against group b streptococcus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951629D0 NO951629D0 (no) | 1995-04-28 |
| NO951629L true NO951629L (no) | 1995-07-03 |
Family
ID=25514876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951629A NO951629L (no) | 1992-11-02 | 1995-04-28 | Konjugat vaksine mot gruppe B streptococcus |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0669985A1 (xx) |
| JP (1) | JPH08505282A (xx) |
| KR (1) | KR100349331B1 (xx) |
| AU (1) | AU689452B2 (xx) |
| CA (1) | CA2146926A1 (xx) |
| FI (1) | FI951979A (xx) |
| HU (1) | HU220198B (xx) |
| IL (1) | IL107458A0 (xx) |
| NO (1) | NO951629L (xx) |
| NZ (1) | NZ258684A (xx) |
| PL (1) | PL177302B1 (xx) |
| RU (1) | RU2209247C2 (xx) |
| WO (1) | WO1994010317A2 (xx) |
| ZA (1) | ZA938171B (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015889A (en) * | 1993-03-19 | 2000-01-18 | Gunnar Lindahl | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| US6284884B1 (en) | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| US7098182B2 (en) | 1998-07-27 | 2006-08-29 | Microbial Technics Limited | Nucleic acids and proteins from group B streptococcus |
| CA2337102A1 (en) * | 1998-07-27 | 2000-02-10 | Richard William Falla Le Page | Nucleic acids and proteins from group b streptococcus |
| EA009885B1 (ru) * | 1998-12-22 | 2008-04-28 | Майкросайенс Лимитед | Применение пептидов бактерий streptococcus группы b, кодирующего их полинуклеотида, вакцина и антитело |
| US6890539B2 (en) | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
| GB9910375D0 (en) * | 1999-05-05 | 1999-06-30 | Lindahl Gunnar | Vaccine composition |
| JP4102186B2 (ja) * | 2000-10-13 | 2008-06-18 | アイディー バイオメディカル コーポレイション | グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原 |
| JP5102487B2 (ja) | 2003-03-07 | 2012-12-19 | ワイス・ホールディングズ・コーポレイション | 院内感染に対する免疫化のための多糖ブドウ球菌表面付着因子キャリアタンパク質接合体 |
| PT2144924T (pt) * | 2007-04-16 | 2016-08-17 | Minervax Aps | Vacina de proteína de fusão |
| KR101734585B1 (ko) | 2008-08-28 | 2017-05-11 | 노파르티스 아게 | 정지 코돈 번역초과에 의한 폴리펩티드 이소형의 세포 표면 표시 |
| WO2017068112A1 (en) | 2015-10-21 | 2017-04-27 | Minervax Aps | Immunogenic fusion protein |
| CA3004631A1 (en) | 2015-12-30 | 2017-07-06 | Minervax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
| WO2018229708A1 (en) | 2017-06-16 | 2018-12-20 | Glaxosmithkline Biologicals Sa | Method of treatment |
| EP4061412A1 (en) | 2019-11-22 | 2022-09-28 | GlaxoSmithKline Biologicals S.A. | Dosage and administration of a bacterial saccharide glycoconjugate vaccine |
| EP4066854A1 (en) | 2021-03-29 | 2022-10-05 | MinervaX | Immunogenic fusion protein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987006267A1 (en) * | 1986-04-16 | 1987-10-22 | The Brigham And Women's Hospital, Inc. | Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| IL95578A (en) * | 1989-09-15 | 1998-08-16 | Gen Hospital Corp | A vaccine made from polysaccharide and protein |
-
1993
- 1993-11-01 IL IL10745893A patent/IL107458A0/xx unknown
- 1993-11-02 ZA ZA938171A patent/ZA938171B/xx unknown
- 1993-11-02 PL PL93308555A patent/PL177302B1/pl not_active IP Right Cessation
- 1993-11-02 RU RU95113472/13A patent/RU2209247C2/ru not_active IP Right Cessation
- 1993-11-02 WO PCT/US1993/010506 patent/WO1994010317A2/en not_active Application Discontinuation
- 1993-11-02 AU AU56654/94A patent/AU689452B2/en not_active Ceased
- 1993-11-02 JP JP6511389A patent/JPH08505282A/ja active Pending
- 1993-11-02 EP EP94902202A patent/EP0669985A1/en not_active Withdrawn
- 1993-11-02 NZ NZ258684A patent/NZ258684A/en unknown
- 1993-11-02 KR KR1019950701811A patent/KR100349331B1/ko not_active IP Right Cessation
- 1993-11-02 HU HU9501260A patent/HU220198B/hu not_active IP Right Cessation
- 1993-11-02 CA CA002146926A patent/CA2146926A1/en not_active Abandoned
-
1995
- 1995-04-26 FI FI951979A patent/FI951979A/fi not_active Application Discontinuation
- 1995-04-28 NO NO951629A patent/NO951629L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0669985A1 (en) | 1995-09-06 |
| JPH08505282A (ja) | 1996-06-11 |
| RU2209247C2 (ru) | 2003-07-27 |
| HU220198B (hu) | 2001-11-28 |
| CA2146926A1 (en) | 1994-05-11 |
| AU5665494A (en) | 1994-05-24 |
| PL308555A1 (en) | 1995-08-21 |
| WO1994010317A2 (en) | 1994-05-11 |
| AU689452B2 (en) | 1998-04-02 |
| HUT70981A (en) | 1995-11-28 |
| WO1994010317A3 (en) | 1994-07-07 |
| FI951979A0 (fi) | 1995-04-26 |
| FI951979A (fi) | 1995-06-29 |
| NO951629D0 (no) | 1995-04-28 |
| KR950704492A (ko) | 1995-11-20 |
| NZ258684A (en) | 1997-04-24 |
| PL177302B1 (pl) | 1999-10-29 |
| IL107458A0 (en) | 1994-02-27 |
| KR100349331B1 (ko) | 2003-01-06 |
| ZA938171B (en) | 1995-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942867L (no) | Syntetisk haemophilus influenzae konjugat-vaksine | |
| NO951629D0 (no) | Konjugat vaksine mot gruppe B streptococcus | |
| NO921364D0 (no) | Hybridpolypeptid | |
| AU6858391A (en) | Bundle tie | |
| MX174031B (es) | Inflador hibrido | |
| DE69307719T2 (de) | Hybridgetriebe | |
| DE69321907T2 (de) | Hybrider koppler | |
| FI944052A0 (fi) | Oraalinen rokote | |
| DE69309672T2 (de) | Klammerbefestigungsvorrichtung | |
| FI930631A (fi) | En roterande motor, foersedd med en utbalanserad vridaxel | |
| ZA937034B (en) | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines | |
| NO970258D0 (no) | Dobbelt hybrid system | |
| ITVE920048A0 (it) | Dispositivo accoppiatore di motopropulsori | |
| DE69204500T2 (de) | Gereinigtes Milben-Allergen. | |
| NO971003D0 (no) | Enteral vaksine mot vaginale infeksjoner | |
| DE69304836D1 (de) | Synchronmotor | |
| AU5626998A (en) | Conjugate vaccine against group B Streptococcus | |
| NL300165I2 (nl) | Babesiavaccin. | |
| DE9213623U1 (de) | Synchronmotor | |
| SE9602149D0 (sv) | Conjugate vaccine against streptococcus pneumoniae | |
| NO943251D0 (no) | Oral vaksine | |
| DE69326536T2 (de) | Antitumor Impfstoff | |
| DE9309360U1 (de) | Zugvorrichtung | |
| SG48106A1 (en) | Pneumococcal polyaccharide conjugate vaccine | |
| ITTO910617A1 (it) | Attrezzatura per posteggiare due vetture sovrapposte. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |